In the world of neurodevelopment, one thing is clear: the earlier the intervention the better. Infancy is a critical time in brain development, and neuroscientists are increasingly identifying factors that can negatively impact cognition and ones that can improve cognition early in life. At the annual meeting of the Cognitive Neuroscience Society (CNS), researchers from the University of Minnesota are presenting new work on two early interventions: one on the potential use of engineered gut microbes for antibiotic-exposed infants and another on a choline supplement to treat infants exposed prenatally to alcohol.
“These talks underscore how patient-based neuroscience can advance the field of neonatal and infant care, providing evidence-based interventions for improving cognition,” says Nathalie Maitre of Nationwide Children’s Hospital, who is chairing the CNS symposium on the neonatal and infant brain. “They also show the interdisciplinary nature of this field, bringing together medical doctors with cutting-edge neuroimaging, as well as other specialized fields like microbiology.”
A microbial approach to infant health
“As a pediatrician specializing in the care of ill newborn infants, I am always concerned with how early-life exposures affect relevant long-term health outcomes,” says Dr. Cheryl Gale of the University of Minnesota. Her team has thus set out to combine microbial genomic analyses, biological computational approaches, and functional brain assessment to better understand neurodevelopment in very young infants.
At CNS, Gale will present new research that shows that infants with different compositions of gut bacteria process auditory and visual stimuli differently during memory tasks. “These results raise the possibility that gut bacteria are involved in the development of brain function,” she says.
The study, published online in Pediatric Research and led by Marie Hickey, compares the brain activity of infants who were given antibiotics to those who were not within their first month of life. The researchers used EEG to record a type of electrical activity called event related potentials (ERPs) in the brains of the infants in response to their mother’s voice or a stranger’s voice – a type of memory called “recognition memory” that can be assessed in preverbal infants before any behavioral changes are apparent.
“Recognition memory is one of the earliest types of explicit memory to develop and is known to be dependent on medial temporal lobe structures, including the hippocampus, the brain region affected by microbiome perturbation in animal models,” Gale explains. Indeed, previous research on the gut-brain connection has been almost exclusively in animal models, making this human study especially valuable and unique. At the same time, the ERP technique has been used extensively in other research to successfully predict a range of behaviors, such as later language development, reading ability, and risk for autism.
The antibiotic-exposed infants’ ERP measurements indicated an abnormal response to their mother’s voices compared to the non-antibiotic-exposed infants. All infants were otherwise healthy, and the researchers worked to control for other variables, such as inflammatory responses and gestational age of the infant.
While the new study showed a relationship between early antibiotic exposure and brain function in participants, the researchers have yet to determine a causal relationship. “We don’t yet know if there is a definitive cause and effect relationship between microbes and brain function in human infants, but future research will hopefully be able to shed light on this,” Gale says.
The work does raise the possibility of creating engineered microbes as an intervention to help people early in life. “Infancy is a critical time window for brain development, when therapeutic interventions can have effects for the life-course,” Gale says.
A supplement to reverse damage
Despite decades of research showing the detrimental effects of consuming alcohol during pregnancy, fetal alcohol syndrome is still common around the world – affecting approximately 8 of 1000 people in the general population, according to a 2017 study in JAMA Pediatrics. The syndrome leaves infants with structural brain abnormalities and cognitive impairments, among other deleterious effects.
Jeff Wozniak remembers encountering his first clinical cases of fetal alcohol spectrum disorders early in his career and realizing for the first time “that this was a very unique, poorly understood population with very high needs.” He also realized that there was an absence of imaging studies in this population. “So I became interested in using some of the tools that we had available here at the University of Minnesota to do high-quality imaging of brain structure and function in this understudied population to learn something about how the brain is altered by prenatal alcohol exposure at the earliest stages of development.”
From this work, he and his colleagues have identified a number of ways in which prenatal alcohol exposure causes the loss of brain cells and the interruption of important developmental processes, including gene expression. For example, he says, alcohol may interfere with genes involved in the myelination process throughout the brain.
Click here to read the full article.
Disclaimer: The views and opinions expressed in this article are those of the authors and do not
necessarily reflect the official policy or position of the Edmonton and area Fetal Alcohol Network Society, its stakeholders, and/or funders.